Biotechnological research in 2025 will be characterised by several key trends, technologies and social challenges. By utilising knowledge and money, mankind hopes to make progress in medicine, agriculture, the environment and industry. Whether it is cancer research, the development of new vaccines or the fight against diseases such as Alzheimer's, Parkinson's or multiple sclerosis. Science is making progress and must also cope with a difficult financing environment due to rising interest rates. Western industrialised countries are facing many challenges: Demographic changes, migration, epidemics and a multitude of geopolitical conflicts. For medicine and society, innovation remains a costly affair in many respects. But the sector is being kissed awake and investors are looking for investment opportunities that promise medium-term success. We make a selection of stocks that we want to highlight this year with a positive risk/reward profile.